The Latest Cardiac and Vascular News
REDWOOD CITY, Calif.–(BUSINESS WIRE)–InterVene, Inc., a privately held medical device company advancing interventional care for venous disease, today announced the successful completion of 30 cases using the Recana® Thrombectomy Catheter System. The cases were performed across the company’s limited US market release and its European first-in-human study. “We’ve had the privilege of partnering with some of the most experienced and knowledgeable physicians to reach this important milestone,” sa
TEL AVIV, Israel–(BUSINESS WIRE)– #aortaEd–Endospan, a privately-held company pioneering solutions for the endovascular repair of aortic arch disease, today announced that the U.S. Food and Drug Administration (FDA) has approved the NEXUS® Aortic Arch Stent Graft. FDA approval was supported by the one-year results of the TRIOMPHE Investigational Device Exemption (IDE) Study evaluating the NEXUS® System shown to effectively treat aortic arch disease, including chronic aortic dissections, in patients at
RESEARCH TRIANGLE PARK, N.C., April 07, 2026 (GLOBE NEWSWIRE) — Merakris Therapeutics today provided an update on recent communications with the U.S. Food and Drug Administration (FDA) related to its Investigational New Drug (IND) application for MTX-001, an investigational biologic being developed for venous leg ulcers (VLUs).
Endospan’s NEXUS branched endovascular stent graft system shown to effectively treat aortic arch disease, including chronic aortic dissections ATLANTA, April 7, 2026 /PRNewswire/ — Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease,…
— Coils minimize artifacts in imaging with high packing density — BOULDER, Colo., April 2, 2026 /PRNewswire/ — The novel, radiopaque, polymer-based embolic coil from Embolization, Inc., is demonstrating consistent success in its limited-market release, with use cases topping 70 coils….
Proven percutaneous AV fistula technology set to re-enter the market with phased rollout in 2026 SAN CLEMENTE, Calif., April 2, 2026 /PRNewswire/ — Ellipsys Medical, Inc. today announced that the Ellipsys® Vascular Access System will once again be commercially available, with initial…
SAN JOSE, Calif.–(BUSINESS WIRE)–Shape Memory Medical Inc., developer of custom shape memory polymers for endovascular applications, today announced enrollment of the first patients in FLAGSHIP, the Company’s prospective, single‑arm, open‑label first‑in‑human study evaluating its investigational False Lumen Embolization (FLE) System for the treatment of aortic dissection. Aortic dissection is a life‑threatening condition in which a tear in the aortic wall creates a secondary channel known as
AUDUBON, Pa., March 31, 2026 /PRNewswire/ — AIROS® Medical, Inc., a medical technology manufacturer specializing in compression therapy systems that treat peripheral vascular disorders, today announced the appointment of Dr. John N. Evans, DPM, FACFAS, DABFAS, to a lead role as Medical…
TAMPA, Fla., March 31, 2026 /PRNewswire/ — Concept Medical Inc. (CMI), a global leader in innovative drug-delivery technology across vascular interventions, proudly announces the presentation of the world’s largest randomised controlled trial of a Sirolimus-coated balloon for Peripheral…
Microbot Medical® Strengthens LIBERTY®’s Position with Publication of its ACCESS PVI Pivotal Study in Leading Peer-Reviewed Medical Journal
